US Broker Ratings

Innoviva, Inc. (INVA) Stock Analysis: A Potential 173% Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Innoviva, Inc. (NASDAQ: INVA) an intriguing prospect, particularly given its substantial potential upside of 173.77% based on the average analyst target..

Indivior PLC (INDV) Stock Analysis: 28.90% Potential Upside Ignites Investor Interest

Investors eyeing the healthcare sector might want to take a closer look at Indivior PLC (NASDAQ: INDV). With a notable potential upside of 28.90% based on current analyst ratings, the..

Alphatec Holdings, Inc. (ATEC) Investor Outlook: Exploring a 65% Potential Upside in Medical Device Innovation

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the healthcare sector, is making waves with its innovative approach to spinal disorder treatments. Specializing in advanced medical devices, this Carlsbad,..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a Potential 323.88% Upside

For investors with a keen interest in the biotechnology sector, Dyne Therapeutics, Inc. (NASDAQ: DYN) presents a compelling narrative. Specializing in the development of therapeutics for neuromuscular diseases, Dyne Therapeutics..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a Potential 139.73% Upside

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a UK-based biotechnology company, is capturing the attention of investors with its innovative approach to drug development and a promising potential upside of nearly 140%...

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A Biotech Play with 65.91% Upside Potential

MoonLake Immunotherapeutics (NASDAQ: MLTX) is commanding the attention of investors as it navigates the competitive waters of the biotechnology sector. With a market capitalization of $3 billion and a specialized..

AtriCure, Inc. (ATRC) Stock Analysis: A Promising Upside of 52.24% in the Healthcare Sector

AtriCure, Inc. (NASDAQ: ATRC), a key player in the medical instruments and supplies industry, is capturing investor attention with a noteworthy potential upside of 52.24%. As a company dedicated to..

CONMED Corporation (CNMD) Stock Analysis: Exploring 27.88% Potential Upside in Medical Device Innovations

CONMED Corporation (NASDAQ: CNMD), a notable player in the healthcare sector, has been capturing the attention of investors with its extensive portfolio of medical devices. Headquartered in Largo, Florida, CONMED..

Artivion, Inc. (AORT) Stock Analysis: Navigating Growth Potential Amidst Mixed Financial Signals

Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its unique product offerings and a market capitalization..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Navigating the Biotech Frontier with 133.7% Revenue Growth

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) has emerged as a noteworthy player in the biotechnology sector, capturing investor attention with its impressive 133.7% revenue growth. As a commercial-stage biopharmaceutical company, SpringWorks..

LifeStance Health Group (LFST): Analyst Ratings Point to a 71% Upside Potential in the Mental Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is carving out a significant niche in the healthcare sector, focusing on the ever-growing demand for mental health services. With a market capitalization of..

89bio, Inc. (ETNB) Stock Analysis: Unpacking the 199.94% Potential Upside

For investors seeking opportunities in the biotechnology sector, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing proposition. With a market capitalization of $1.43 billion, this clinical-stage biopharmaceutical company, headquartered in San..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Promising 40% Upside in Biotechnology

Scholar Rock Holding Corporation (NASDAQ: SRRK) is making waves in the biotechnology sector with a promising pipeline and notable analyst support, offering a potential upside of 40.22% based on its..

Surgery Partners, Inc. (SGRY) Stock Analysis: A 41% Upside Potential and Analysts’ Consensus

Surgery Partners, Inc. (NASDAQ: SGRY) has captured the attention of investors with its dynamic presence in the healthcare sector, particularly in the medical care facilities industry. Headquartered in Brentwood, Tennessee,..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 27% Potential Upside in the Healthcare Sector

Investors eyeing the healthcare sector may find UFP Technologies, Inc. (UFPT) an intriguing opportunity, especially considering its robust growth metrics and potential upside. With a market capitalization of $1.88 billion,..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 27% Upside Potential

For investors seeking opportunities in the healthcare sector, Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling case. With a market capitalization of $1.11 billion, Pacira BioSciences operates in the competitive..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 56.90% Potential Upside in the Healthcare Sector

Neogen Corporation (NASDAQ: NEOG) is making waves in the healthcare sector, particularly within the diagnostics and research industry, with a remarkable potential upside of 56.90%. As investors search for promising..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 25.83% Upside Potential in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a prominent player in the healthcare sector, specifically within the niche of medical instruments and supplies. Headquartered in Burlington, Massachusetts, this company has carved..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a 23.73% Potential Upside for Investors

Supernus Pharmaceuticals, Inc. (SUPN), a key player in the healthcare sector, is attracting significant investor attention with a compelling potential upside of 23.73%. This biopharmaceutical company, headquartered in Rockville, Maryland,..

PACS Group, Inc. (PACS) Investor Outlook: A 136% Upside Potential in Healthcare

PACS Group, Inc. (PACS) is an intriguing player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $2 billion, PACS Group operates a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds